Compositions, Formulations and Methods for Treating Ocular Diseases
Copyright © Targeted News Service 2024
2024-11-26
ALEXANDRIA, Virginia, Nov. 26 -- EYEPOINT PHARMACEUTICALS, INC., Watertown, Massachusetts has been assigned a patent (No. US 12152023 B2, initially filed March 3, 2022) developed by four inventors Kevin Peters, Cincinnati, Ohio; Robert Shalwitz, Bexley, Ohio; John Janusz, West Chester, Ohio; and Alexander Smith, Apex, North Carolina, for "Compositions, formulations and methods for treating ocular diseases." . . .